Invesco Ltd. Sangamo Therapeutics, Inc Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Invesco Ltd. holds 288,019 shares of SGMO stock, worth $103,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares

288,019

Previous 162,274 77.49%

Holding current value

$103,686

Previous $87,000 120.69%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.42 - $1.38 $52,812 - $173,528	125,745 Added 77.49%	288,019 $192,000
Q4 2023 Feb 12, 2024	SELL	$0.3 - $0.63 $6,781 - $14,241	-22,605 Reduced 12.23%	162,274 $87,000
Q3 2023 Nov 13, 2023	BUY	$0.58 - $1.47 $3,246 - $8,227	5,597 Added 3.12%	184,879 $110,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $1.74 $13,099 - $20,533	11,801 Added 7.05%	179,282 $233,000
Q1 2023 May 12, 2023	BUY	$1.66 - $3.67 $43,835 - $96,913	26,407 Added 18.72%	167,481 $294,000

Q4 2022 Feb 13, 2023	BUY	$2.77 - $5.07 $17,683 - $32,366	6,384 Added 4.74%	141,074 $442,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $16,136 - $24,147	-3,779 Reduced 2.73%	134,690 $660,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $33,724 - $63,851	10,282 Added 8.02%	138,469 $573,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $219,089 - $327,587	41,891 Added 48.54%	128,187 $744,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $51,124 - $76,932	-7,013 Reduced 7.52%	86,296 $646,000
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $6.38 Million - $8.51 Million	-708,564 Reduced 88.36%	93,309 $840,000
Q2 2021 Aug 17, 2021	BUY	$10.17 - $12.64 $451,649 - $561,342	44,410 Added 5.86%	801,873 $9.6 Million
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $555,130 - $869,942	51,023 Added 7.22%	757,463 $9.49 Million
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $791,786 - $1.56 Million	85,784 Added 13.82%	706,440 $11 Million
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $5.28 Million - $7.02 Million	562,474 Added 966.75%	620,656 $5.87 Million
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $37,154 - $70,778	-5,983 Reduced 9.32%	58,182 $521,000
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $197,045 - $345,318	39,019 Added 155.17%	64,165 $409,000
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $13,233 - $19,281	-1,648 Reduced 6.15%	25,146 $210,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $9,448 - $12,757	-1,044 Reduced 3.75%	26,794 $242,000
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $7.6 Million - $11.3 Million	-868,229 Reduced 96.89%	27,838 $300,000
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $2.1 Million - $3.48 Million	271,590 Added 43.49%	896,067 $8.55 Million
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $5.94 Million - $10.4 Million	624,477 New	624,477 $7.17 Million

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account